Victoria Bae-Jump - JoVE Visualize

Showing results (61-70 of 67) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 67 results.

Cancer Medicine|December 7, 2019

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancersNicholas W Bateman, Pang-Ning Teng, Erica Hope, et al.

Gynecologic Oncology|July 12, 2025

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.

Journal of Experimental & Clinical Cancer Research : CR|February 9, 2021

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancerStuart R Pierce, Ziwei Fang, Yajie Yin, et al.

Gynecologic Oncology|February 22, 2025

Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.

NPJ Precision Oncology|April 17, 2018

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025

Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.

Gynecologic Oncology|September 25, 2023

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.

Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 67 results.

Cancer Medicine|December 7, 2019

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancersNicholas W Bateman, Pang-Ning Teng, Erica Hope, et al.

Gynecologic Oncology|July 12, 2025

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.

Journal of Experimental & Clinical Cancer Research : CR|February 9, 2021

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancerStuart R Pierce, Ziwei Fang, Yajie Yin, et al.

Gynecologic Oncology|February 22, 2025

Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.

NPJ Precision Oncology|April 17, 2018

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025

Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.

Gynecologic Oncology|September 25, 2023

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.

Pageof 7